Deciphera Pharmaceuticals

Today, on Rare Disease Day, we’re highlighting tenosynovial giant cell tumor (#TGCT), a rare, locally aggressive neoplasm?that can negatively impact quality of life for those affected. Learn more:?https://lnkd.in/g-_SCzFn #RareDiseaseDay Rare Disease Day

We are excited about the recent FDA approval of a new medicine for people living with tenosynovial giant cell tumor (#TGCT). Read more: https://bit.ly/3PZlmwY Learn more: ?https://bit.ly/4b8uDwn

We are proud to announce the FDA approval of a new medicine for people living with tenosynovial giant cell tumor (#TGCT). Read more in today’s press release: https://bit.ly/3PZlmwY Learn more: https://bit.ly/4b8uDwn

On this International Day of Women and Girls in Science, we express our gratitude for the incredible and dedicated work the women at Deciphera do to defeat #cancer and make a difference for the patient groups and communities in which we live and work. #IDWGS #WomenInScience

Today is #WorldCancerDay, organized by Union for International Cancer Control (UICC) to raise awareness about #cancer and encourage its prevention. At Deciphera, we're working to discover and develop important new medicines to improve the lives of people living with cancer. #UnitedByUnique

Today, ONO PHARMACEUTICAL CO., LTD., the parent company of Deciphera, announced its financial results for the third quarter of fiscal year 2024. Read more: https://lnkd.in/gyfytyA4

Open Roles Spotlight ?? Deciphera Pharmaceuticals is growing, which means that we're seeking talented and passionate individuals to join us in our mission to defeat cancer! ?????? I'm still actively seeking to connect with highly skilled and qualified candidates for these exciting roles - - Associate Director, Regulatory Affairs (Onsite in Waltham, MA or remote in the US) - https://smrtr.io/pkSwG - Associate Director, Clinical Data Management (Onsite in Waltham, MA) - https://smrtr.io/pj8gN - Medical Science Liaison, Mid-West (IL, IN, KY & MI) - https://smrtr.io/pjSt5 Aside from the impactful work, we like to keep things fun around here with some pretty amazing perks: ?? An annual lifestyle allowance ?? Summer vacation bonus ?? Non-accrual paid time off ...and much more! Apply now or send me a message ??

Please join us in welcoming Ryota Udagawa, Deciphera’s new President and Chief Executive Officer. Ryota has been a part of the ONO PHARMACEUTICAL CO., LTD. team since 2002, and joined as Deciphera’s CEO at the end of 2024. Welcome, Ryota!

This weekend, Margarida Duarte, Deciphera’s Global Chief Commercial Officer, will participate on the “Europe Matters: Creating Value for US Biotechs” panel hosted by INSEAD at #JPM25. Check it out!

Happy holidays from our Deciphera team! As we reflect on an exciting 2024, we’re grateful to be part of this fantastic team and looking forward to another great year. See you in 2025! #TheDecipheraDifference